Acupuncture recommendations for migraine in headache treatment guidelines: a systematic review
Abstract
OBJECTIVE: To evaluate the quality of global headache guidelines regarding the recommendation of acupuncture for migraine treatment.
METHODS: We searched 31 electronic databases and 15 guideline repositories from inception to October 2024, without language restrictions. We identified 25 guidelines meeting our inclusion criteria, and evaluated these for methodological, reporting and recommendation quality using the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument, Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist, and AGREE Recommendations Excellence (REX) tool, respectively. We present our findings using descriptive statistics, and assess interrater reliability using intraclass correlation coefficients.
FINDINGS: Of the 25 guidelines analysed, we observed that 40.0% (10/25) recommended acupuncture and 32.0% (8/25) provided conditional recommendations. Of the 18 guidelines recommending acupuncture, 77.8% (14/18) lacked procedural details; only 22.2% (4/18) specified treatment frequency and 16.7% (3/18) described needling techniques. We found that methodological quality was suboptimal, with the domain clarity of presentation scoring highest (75.2%) and applicability lowest (20.3%). We noted that reporting quality was inadequate, particularly in the review and quality assurance domain (18.8%). Only 4.0% (2/25) of guidelines provided high-quality acupuncture recommendations. The 2023 World Federation of Acupuncture-Moxibustion Societies…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.